Etoricoxib for Postoperative Pain After Thyroid Surgery
Status:
Unknown status
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is evaluate the analgesic efficacy and safety profile of the Cox-2
specific analgesic Etoricoxib (arcoxia®) when administrated pre and postoperatively for
controlling pain in adult patients undergoing thyroid surgery. Patients will be followed up
in the immediate postoperative period, during the first postoperative (POD) day and in POD 2,
3 and 7. It is expected that with the addition of Etoricoxib, patients will experience less
pain during the overall postoperative period and also a better quality of recovery when
compared with the traditional analgesic regimen.